Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 3145742, 7 pages
Review Article

Manipulation of Innate and Adaptive Immunity through Cancer Vaccines

UF Brain Tumor Immunotherapy Program, Preston A. Wells Jr. Center for Brain Tumor Therapy, Department of Neurosurgery, University of Florida, Gainesville, FL, USA

Correspondence should be addressed to Elias J. Sayour; ude.lfu@ruoyase

Received 2 December 2016; Accepted 4 January 2017; Published 6 February 2017

Academic Editor: Said Dermime

Copyright © 2017 Elias J. Sayour and Duane A. Mitchell. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • Hyoung Jin Kim, and Hong-Jin Kim, “Current status and future prospects for human papillomavirus vaccines,” Archives of Pharmacal Research, 2017. View at Publisher · View at Google Scholar
  • Wentao Yu, Hong Qu, Guangming Cao, Chongdong Liu, Haiteng Deng, and Zhenyu Zhang, “MtHsp70-CLIC1-pulsed dendritic cells enhance the immune response against ovarian cancer,” Biochemical and Biophysical Research Communications, 2017. View at Publisher · View at Google Scholar
  • ZhenLong Ye, HuaJun Jin, QiJun Qian, and Qiming Qian, “Cancer vaccine: Learning lessons from immune checkpoint inhibitors,” Journal of Cancer, vol. 9, no. 2, pp. 263–268, 2017. View at Publisher · View at Google Scholar
  • Keith Dredge, Todd V. Brennan, Edward Hammond, Jason D. Lickliter, Liwen Lin, Darryn Bampton, Paul Handley, Fleur Lankesheer, Glynn Morrish, Yiping Yang, Michael P. Brown, and Michael Millward, “A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours,” British Journal of Cancer, 2018. View at Publisher · View at Google Scholar